Abstract
Background
Fetal growth restriction (FGR) increases risk for development of obesity and type 2 diabetes. Using a mouse model of FGR, we tested whether metabolic outcomes were exacerbated by high-fat diet challenge or associated with fecal microbial taxa.
Methods
FGR was induced by maternal calorie restriction from gestation day 9 to 19. Control and FGR offspring were weaned to control (CON) or 45% fat diet (HFD). At age 16 weeks, offspring underwent intraperitoneal glucose tolerance testing, quantitative MRI body composition assessment, and energy balance studies. Total microbial DNA was used for amplification of the V4 variable region of the 16 S rRNA gene. Multivariable associations between groups and genera abundance were assessed using MaAsLin2.
Results
Adult male FGR mice fed HFD gained weight faster and had impaired glucose tolerance compared to control HFD males, without differences among females. Irrespective of weaning diet, adult FGR males had depletion of Akkermansia, a mucin-residing genus known to be associated with weight gain and glucose handling. FGR females had diminished Bifidobacterium. Metabolic changes in FGR offspring were associated with persistent gut microbial changes.
Conclusion
FGR results in persistent gut microbial dysbiosis that may be a therapeutic target to improve metabolic outcomes.
Impact
-
Fetal growth restriction increases risk for metabolic syndrome later in life, especially if followed by rapid postnatal weight gain.
-
We report that a high fat diet impacts weight and glucose handling in a mouse model of fetal growth restriction in a sexually dimorphic manner.
-
Adult growth-restricted offspring had persistent changes in fecal microbial taxa known to be associated with weight, glucose homeostasis, and bile acid metabolism, particularly Akkermansia, Bilophilia and Bifidobacteria.
-
The gut microbiome may represent a therapeutic target to improve long-term metabolic outcomes related to fetal growth restriction.
Similar content being viewed by others
Introduction
Fetal growth restriction (FGR), defined as the failure of a fetus to achieve its genetic growth potential, impacts approximately 20% of pregnancies in low- and middle-income countries and 4–10% in the U.S.1,2,3 The underlying cause of impaired fetal growth may be due to maternal malnutrition or chronic disease, placental disorders such as preeclampsia, environmental factors like high altitude or cigarette smoke exposure, or fetal causes including infection or genetic disorders.2,4 Later in life, formerly FGR individuals are susceptible to metabolic syndrome including obesity, type 2 diabetes, and hypertension.2,5,6
Rapid weight gain after FGR further exacerbates metabolic morbidity. In humans, school-aged children with rapid postnatal weight gain after fetal growth restriction have higher BMI,7 higher central and visceral adiposity8,9,10 and decreased lean muscle mass.9 In mice, rapid weight gain early in life results in insulin resistance, increased peripheral and central fat mass, adipocyte hypertrophy, and elevated leptin expression.11,12 However, inadequate growth in early life is associated with poor neurodevelopmental outcomes7,13 making it critical to target sufficient postnatal growth while mitigating the risks of rapid catch-up growth. In an effort to prevent insufficient weight gain, many FGR infants are fed concentrated infant formulas and high fat/high calorie complementary foods, despite the possible long-term health consequences.
There are multiple mechanisms which contribute to impaired metabolic outcomes in FGR into adulthood including epigenetic changes,6 higher adiposity and lower lean body mass,4,14 fewer pancreatic β cells, and increased hepatic insulin resistance.15 In animal models, FGR contributes to central insulin resistance through hypothalamic gene expression,11,16,17 a change further exacerbated by weaning to a high fat diet.16 Although important, there is currently limited capacity to substantially modify these factors in a clinical setting.
Emerging evidence strongly suggests an important role for the gut microbiome, which can be modified by dietary intake in infancy,18 childhood,19 and adulthood.20 The gut microbiome regulates nutrient absorption, digestion, and energy expenditure21 and is known to influence long-term health of the entire body, including cardiovascular health and weight gain/obesity.22,23,24 Disturbances in gut microbial composition (dysbiosis) have been reported in FGR piglets25 and rats26 and in humans in the first few days of life,27 but the role of the microbiome in FGR metabolic outcomes has not yet been explicitly studied, nor has the influence of offspring sex.
In this study, we sought to determine whether a high fat weaning diet impacts growth and metabolic outcomes in a mouse model of FGR. Our studies also examined whether gut microbial ecology was altered in adult mice after FGR and whether any adult outcomes correlated with specific fecal microbial taxa.
Methods
Ethical approval
All animal experiments and procedures were approved by the University of Colorado Institutional Animal Care and Use Committee and conducted in compliance with the American Association for Accreditation for Laboratory Animal Care at the Perinatal Research Center at the University of Colorado School of Medicine (Aurora, CO).
Murine model of fetal growth restriction
The FGR model has been previously published by our group28 and is based on a calorie-restricted diet as described.29 Briefly, we used timed syngeneic matings in C57BL6/J female mice bred in-house. Food intake (in grams) was quantified daily from gestation day E9 through delivery for pregnant dams with ad libitum access to food. Daily intakes (considered 100% of needs) were established for each gestational day and differed by dam weight.
For the present study, dams had ad libitum access to food during gestation days E0–E8. From gestation day E9 through parturition, pregnant dams continued with ad libitum feeds (control) or calorie restricted diet (FGR) that provided 70% of needs. Food was weighed and provided daily. To verify induction of FGR, a cohort of pregnant dams were euthanized by CO2 intoxication followed by cervical dislocation at day E18.5. Pups were dissected from the placenta and amniotic sack and weighed on an electronic scale. After delivery FGR dams were returned to ad libitum feeding for the duration of lactation. Only litters with at least 6 surviving pups were used for long-term study to avoid influences of litter size12,30,31 on postnatal weight gain.
High fat diet
Twenty-one-day-old control and FGR offspring were randomized to receive control diet (CON; 7% fat from corn oil, 3.8 kcal/g; Harlan TD.09283) or high fat, high sucrose Western diet (HFD, 45% calories from fat, 34% w/w of sucrose, 4.7 kcal/g; Harlan TD.08811). There were four groups for each sex: (1) Control mice fed CON; (2) Control mice fed HFD; (3) FGR mice fed CON; and (4) FGR mice fed HFD. Animals were provided food and water ad libitum and weighed weekly.
Metabolic studies
An intraperitoneal glucose challenge was performed at age 16 weeks as previously described.32 In the morning mice were placed in clean cages with ad libitum access to water but no food. After 6 h, fasting glucose was measured with a Nova StatStrip Xpress2 Glucose Meter (Nova Biomedical, Waltham, MA) from the tail vein following tail snip. Mice were administered 2 g/kg of sterile 30% glucose solution intraperitoneally and glucose was measured at 15, 30, 60, 90, 120, and 150 min. Additional blood was collected at the end of the 6-h fast and 15 min after glucose injection. Blood was allowed to clot for at least 20 min on ice, then spun at 2000 × g at 4 °C for 10 min to collect serum. Insulin was measured using Rat/Mouse Insulin ELISA Kit (EMD MilliporeSigma, St. Louis, MO) per manufacturer’s instructions. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as [fasting insulin concentration (pmol/L) × fasting glucose concentration (mmol/L)] / 22.5.
Body composition was assessed in live mice at age 16–18 weeks by quantitative magnetic resonance (EchoMRI-900; EchoMRI, Houston, TX) in the University of Colorado Nutrition Obesity Research Center Small Animal Energy Balance Lab (NORC-SEBL). Echo MRI uses nuclear magnetic resonance relaxometry to directly measure total body fat and lean mass. The scan lasts 2–3 min and animals are gently restrained in a clear plastic tube without sedation. Percent fat mass was calculated as fat mass (g) / body weight (g).
Calorimetry studies were performed on a subset of animals (n = 7–9 per group per sex) for 4–8 days in the NORC-SEBL using the Comprehensive Lab Animal Monitoring System (Columbus Instruments; Columbus, OH) which assesses oxygen consumption, carbon dioxide production, food intake, and activity among other measures. All mice had ad libitum access to water and CON or HFD as appropriate. Measurements, obtained every 18 min, were averaged over the entire day as well as independently for light (14 h) and dark (10 h) periods. Data from female mice were limited to either 4 or 8 days to account for variations associated with the estrous cycle. Data were discarded by the NORC-SEBL team if the measurements appeared in error (e.g., no measured water consumption). Respiratory quotient was calculated as the volume of carbon dioxide produced divided by the volume of oxygen consumed.
After all experiments, mice were euthanized by CO2 intoxication followed by cervical dislocation. Liver and pancreas were dissected, and organ weight was adjusted for total body weight.
Statistical analysis
Statistical analyses and visualizations were performed in R v4.0.5 or GraphPad Prism v9.3.1. Outliers were removed if greater than 1.5 x the interquartile range (IQR). Shapiro–Wilk test was used to assess assumption of normality. Student’s t-test (if normal distribution) or Mann–Whitney test (if non-normal distribution) were used to assess differences in litter size and pup weight. Linear regression was used to determine whether growth rates differed between control and FGR offspring from weaning to 16 weeks. Area under the glucose tolerance curve (AUC) was calculated for each individual animal in Graph Pad Prism v9.4.1. Two-way analysis of variance (ANOVA, if normal distribution) or the Kruskal-Wallis test (if non-normal distribution) were used to assess outcome differences between groups based on fetal growth conditions and weaning diet. Females and males were analyzed separately.
Fecal microbiome assessment and analysis
Sixteen-week-old animals were placed individually in empty clean cages until one or more fecal pellets were produced. Pellets were stored at −80 °C. The fecal microbiome was assessed as previously described.33 Briefly, bacterial DNA was extracted with the DNeasy PowerSoil HTP 96 kit (Qiagen, Redwood City, CA) including a bead-beating step in 96-well PowerBead plates on a TissueLyser II (Qiagen). Genomic DNA was used for amplification of the 16 S rRNA gene V4 variable region using 515 F/806 R primers. Paired-end sequencing of pooled amplicons was performed using an Illumina MiSeq Instrument (Illumina, San Diego, CA).
Data processing was performed using QIIME2. We used the microbiome package ‘core’ function to retain taxa with at least 5 counts in 5% of samples. Microbiota counts, sample metadata and taxonomy information were imported using the phyloseq34 package. Alpha diversity was determined using the microeco package35 and two-way ANOVA was used to test differences between groups. Beta diversity was assessed using Aitchison distance, Bray–Curtis dissimilarity, and Jaccard dissimilarity. Multidimensional scaling was used to visualize groups for each sex, and statistical difference was tested using PERMANOVA with 999 permutations. Multivariable associations between groups and taxonomic abundance were assessed using the MaAsLin2 package.36 Fetal growth and weaning diet were considered fixed effects, and analyses were adjusted for co-housing. Taxa were agglomerated at the genus level. All P-values were false discovery rate-adjusted (Benjamini–Hochberg, q-values) and features with q < 0.3 were considered significant (default for MaAsLin2). For clarity, all findings passing an un-adjusted P < 0.05 are also included in results. The OTU relative abundance is visualized on a log-transformed axis in figures.
We performed unsupervised principal components analysis (PCA) of genus-level taxa and biplot visualization following centered-log ratio transformation using the microviz package.37 The SILVA database was used to determine predicted bacterial functions of genus-level taxa.38 Group differences were determined using the tax4fun function in the microeco package. Relationships between microbial taxa abundance and metabolic outcomes were summarized using distance-based redundancy analysis (db-RDA) Bray–Curtis distances. Associations of microbial taxa with phenotypic outcomes were performed using Spearman correlations using the microeco cal_cor function. Due to the high number of zeros, particularly in taxa of interest, we used feature modification that preserved ratios between non-zero values using the package zCompositions as previously described.39 We then used Pearson correlation to assess relationships between taxa abundance and measured outcomes.
Results
Maternal calorie restriction induces FGR
Calorie restricted dams gained less weight over the second half of gestation (Fig. S1A) without difference in litter size between groups (Fig. 1a). FGR fetuses were on average 17% smaller than control fetuses at gestational day E18.5 (Figs. 1b and S1B). On postnatal days 0 and 1, average weight of FGR pups was less than controls (Figs. 1c and S1D, E) with catch-up growth occurring by postnatal day 2 (Figs. 1d and S1F).
FGR males gain weight faster on a high fat diet
Control (n = 5 litters, 42 pups) and FGR (n = 7 litters, 48 pups) offspring were randomized at day of life 21 to control (CON) or high fat (HFD) diet. Body weights at randomization did not differ between female and male offspring, control versus FGR mice, or CON versus HFD groups (Fig. S1G, H). High fat diet resulted in differentiation between CON and HFD fed mice after 3–4 weeks (Fig. S1G, H). Compared with their counterparts fed CON, mice fed HFD weighed more at 16 weeks of age: control males +31.6%, FGR males +38.8%, control females +33.9%, and FGR females +31.5%. Linear regression was used to examine growth rates of HF diet fed animals from 3–7 weeks (from weaning to puberty) and 7–16 weeks (post-pubertal). Male control HFD (slope 1.24, 95% CI: 1.05–1.42) versus FGR HFD mice (slope 1.50, 95% CI: 1.32–1.64) revealed faster post-pubertal weight gain in FGR males (p = 0.03; Fig. 1e), a pattern not observed in females (p = 0.8; Fig. 1f) or before puberty. Final body weights between control and FGR mice at 16 weeks did not statistically differ for either sex or either diet. At age 16 weeks, lean (Fig. 1g, i) and fat mass were assessed by quantitative MRI. Percent fat mass increased in all HFD groups and was not statistically different between control and FGR mice (Fig. 1h, j).
FGR males have impaired glucose tolerance on high fat diet
Intraperitoneal glucose tolerance testing was conducted after a 6-h morning fast at age 16–17 weeks (n = 7–13 per sex per group). Fasting glucose and insulin were impacted by diet but not growth (Table S1). FGR HFD males had higher fasting glucose compared to FGR CON males (Fig. 2a, b). Fasting insulin was higher in control HFD compared to control CON males, but did not otherwise differ based on in utero growth or weaning diet (Fig. 2c, d). Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated from fasting insulin and fasting glucose. Two-way ANOVA showed an effect of diet in both sexes and an effect of intrauterine growth in females only (Table S1). HOMA-IR was higher in control HFD females compared to control CON females without statistical differences between FGR female diet groups (Fig. 2e, f). Both control and FGR males had higher HOMA-IR in the HFD groups; differences between control and FGR HFD groups did not reach significance. HFD resulted in prolonged glucose elevation in control females and FGR males only. At 150 min FGR males fed HFD had significantly higher glucose levels compared to control HFD males (Fig. 2g, h and Table S1). AUC was calculated for each individual mouse then grouped by sex, growth, and diet (Fig. 2i, k and Table S1). In males, FGR but not controls had higher AUC when challenged with HFD (Fig. 2j and Table S1). Both control and FGR females fed HFD had higher AUC compared to CON diet counterparts (Fig. 2l). Diet was a significant driver of AUC in males with an interaction between diet and growth, but intrauterine growth did not reach significance (Table S1). Diet was also a significant driver of AUC in females but the effect of in utero growth was not (Table S1). Liver and pancreas weights as a percent of body weight did not differ based on intrauterine growth (Fig. S2).
FGR females have lower resting energy expenditure and respiratory quotient
A total of 37 females and 37 males (n = 8–10 per sex per group) had successful calorimetry studies. Compared to respective CON fed animals, animals fed HF diet had higher average daily calorie intake, higher resting energy expenditure, and higher total energy expenditure. None of these measures differed based on in utero growth (Fig. S3A–F). Total activity levels (including both moving around the cage and stationary movements such as grooming) did not differ between groups (Fig. S3G, H). Energy balance, defined as energy consumed minus energy expended, was 2.8 to 3.3-fold higher in all HFD groups compared to respective CON group, but did not differ between control and FGR animals (Fig. S3I, J). All HFD groups had lower respiratory quotient compared to respective CON group (Fig. S3K, L). FGR CON females had lower respiratory quotient compared to control CON females (Fig. S3L).
Microbiome
Alpha diversity was assessed using the microeco package and tested for differences using two-way ANOVA. Neither intrauterine growth nor weaning diet altered alpha diversity in adulthood (Table 1). Beta diversity was assessed by Jaccard and Bray–Curtis dissimilarity, as well as Aitchison distance, which may better avoid compositionality bias.40 Beta diversity differed in males for both diet and intrauterine growth as assessed in all three methods (Fig. 3a and Table 2). In females, beta diversity differed by intrauterine growth oly based on Aitchison distance only (Fig. 3b and Table 2).
Unsupervised PCA in male mice identified the genera Akkermansia and Rikenella as the main distinguishing taxa between control and FGR offspring, and Sutterella and Anaeroplasma differentiated between diet (Fig. 4a). Using taxa aggregated at the genus level, MaAsLin2 was used to evaluate for gut microbial differences between control and FGR mice of both sexes at 16 weeks. Relative Akkermansia abundance was substantially reduced in 16-week-old FGR males in both diet groups (Fig. 4b–d and Table 3). In CON fed females, adult FGR offspring had decreased abundance of Bifidobacterium and increased relative abundance of Sutterella, while HFD fed females had increased Prevotella and decreased Bilophila (Table 4).
We next asked whether abundance of any taxa was associated with measured metabolic outcomes including weight gain velocity, percent fat mass, fasting glucose, HOMA-IR and GTT AUC. We focused on males due to the presence of greater microbial and metabolomic differences. In adult males, dbRDA of genus-level taxonomic abundance and outcomes showed negative alignment of Akkermansia and metabolic outcomes, particularly velocity of weight gain, % fat mass, GTT AUC and HOMA-IR (Fig. 5a). In CON-fed FGR males, there was a strong positive correlation between lean mass and relative abundance of Akkermansia, Ruminococcus, and other genera (Fig. 5b). Predicted bacterial functions showed differences between control and FGR males including metabolic functions (Fig. 5c). Evaluation of relationships between zero-adjusted taxonomic abundance of Akkermansia and Bilophila with outcomes revealed associations in control CON males only: higher Akkermansia abundance was associated with lower fasting glucose (Fig. 5d), and higher Bilophila abundance was associated with lower GTT AUC (Fig. 5e). These associations were not significant in females, FGR males, or HFD-fed control males.
Discussion
Fetal nutrient insufficiency results in developmental programming changes to prepare for postnatal nutrient scarcity.6 Although typically adaptive in utero, these changes are hypothesized to predispose to metabolic impairments such as obesity, type 2 diabetes, and cardiovascular disease in the setting of postnatal nutrient abundance.41 The long-term metabolic consequences of fetal growth restriction are well documented2 as are the risks of subsequent rapid postnatal growth.10 Little research has focused on the effect of high fat diet consumption later in life or on a possible role of gut microbial dysbiosis. In this study, we report adverse effects of high fat diet challenge following FGR and persistent gut microbiome changes into adulthood. In particular, our results demonstrate faster weight gain, glucose intolerance, and reduced relative abundance of Akkermansia in male mice with a history of FGR.
Among males, FGR mice fed HFD gained weight faster than control HFD mice, despite equivalent energy balance. Prior work in mice reported similar findings, although only studied male offspring.12,42 In one study, FGR males fed high calorie diet had distinctly higher weight compared to control animals starting around age 4 months, even though energy intake did not differ.12 At our study’s conclusion, weight was not statistically different between CON-fed control and FGR animals of either sex; however, endpoints were obtained earlier than existing studies (16 weeks versus 6-9 months), raising the possibility that extension to older ages may further distinguish our two groups.
We also report impaired glucose handling in FGR HFD males compared to control HFD males, without differences in females. Prior work, including in a model similar to ours,43 also showed impaired glucose handling in FGR males at 6 to 9 months of age,12,43 though there was no consideration of sex as a biologic variable. Sex differences in response to HFD are well documented in mice, generally demonstrating relative protection in females.44,45 In this cohort, control males fed HFD had higher fasting insulin and higher HOMA-IR compared to CON-fed control males, but IP-GTT testing did not differ. In contrast, FGR males showed glucose intolerance in response to HF diet, indicating higher sensitivity to dietary challenge. In addition, development of impaired glucose handling prior to weight divergence between the two groups suggests that glucose intolerance is an early phenomenon in FGR and may drive cardiovascular disease and excess weight gain. We did not see statistical differences in serum insulin levels 15 min after glucose injection, suggesting against impaired insulin secretion. However, to more deeply understand the etiology of glucose intolerance, future work can include targeted studies of insulin signaling including insulin tolerance testing and/or metabolic clamp studies.11,46
Sexual dimorphism has been reported previously in multiple FGR animal models as well as in humans.47 Maternal calorie restriction in mice caused sex differences in the offspring’s response to lipopolysaccharide injection.28 In a hypoxia-induced FGR mouse model, adult female mice had airway hyper-responsiveness compared to hypo-responsiveness in adult males.48 In a rat FGR model, white adipose tissue progenitor cells from males had higher expression of genes related to adipocyte differentiation.49 Growth-restricted male guinea pigs had a more adverse response to a high fat diet.50 Sexual dimorphism has also been noted in pig17 and non-human primate51,52 models of FGR. In humans, fetuses respond to intrauterine exposures in a sexually dimorphic manner, which may impact postnatal outcomes.47 Male infants have well-documented inferior neonatal morbidity and mortality compared to females, including worse survival and higher rates of serious complications such as necrotizing enterocolitis.53
Although sex hormones49 and epigenetic changes6 may partially explain differences related to intrauterine growth, the role of the intestinal microbiome has been understudied. Fecal microbial taxa have been shown by multiple groups to be associated with feeding tolerance54,55 and growth56,57 during infancy. The microbial relationship with growth and feeding is particularly critical for FGR neonates who are more likely to receive antibiotics58 or to have enteral feeds delayed or interrupted due to feeding intolerance59 or concern for necrotizing enterocolitis.60 Recent work found an association between neurodevelopment and early fecal microbiota in infants with FGR.27 Gut microbial composition could, therefore, have life-long effects on the growth and development of FGR infants and is a logical target for intervention.
Disturbances in gut microbial composition have been reported in FGR piglets,25,61 rats,26 and in human neonates.27 In our mouse model, FGR resulted in persistent fecal microbial changes into adulthood. In particular, FGR males had substantial reduction in relative abundance of Akkermansia, a mucin-residing genus known to be associated with intestinal barrier integrity, glucose handling, and weight gain in mice62,63,64 and humans.65,66,67,68 Akkermansia supplementation in mice fed a high sugar diet resulted in improved glucose control and insulin secretion.62 In human subjects with overweight and obesity, Akkermansia improved insulin sensitivity, weight, adiposity, systemic inflammation, and serum lipopolysaccharide levels, a marker of intestinal barrier strength.69 There are multiple proposed mechanisms for the systemic effects of Akkermansia,67 many of which are impaired in the setting of FGR. Akkermansia improves intestinal barrier function69 known to be altered in FGR models;70,71,72 increases short-chain fatty acid production,67 diminished in FGR pigs;61 and facilitates bile acid metabolism,62 altered in FGR piglets.73 We also report positive correlation of lean mass with Akkermansia abundance in FGR males. Skeletal muscle mass is a major driver of insulin sensitivity74 and known to be reduced across the lifespan in humans with FGR.4 Recent work showed improved muscle strength with Akkermansia supplementation in a mouse model of muscle atrophy.75 Additional studies are needed in the FGR population to determine whether Akkermansia depletion may be related to short- and long-term outcomes.
Male FGR offspring also had reduced relative abundance of Blautia, an acetic acid producer whose depletion has been associated with type 2 diabetes, obesity and visceral adiposity76,77 and is being tested as a possible therapeutic.78 We also detected reduced abundance of Bilophilia, known to be depleted with defects of bile acid conjugation.79 The exact implications of this finding may depend on which specific bacteria are diminished, as species within this genus have been associated with either beneficial,80 or detrimental metabolic81 or inflammatory82,83 effects. Future work is needed to identify bacterial species and function, and what role bile acids or short chain fatty acids may have in health and disease after FGR.
Fecal microbial alterations due to FGR were less pronounced in adult female offspring. Notably, relative abundance of Akkermansia did not differ, supporting a possible role of Akkermansia in driving male metabolic outcomes. We also report decreased relative abundance of the beneficial bacteria84 Bifidobacterium, and increased abundance of Sutterella, previously shown to have mild pro-inflammatory effects.85 Both genera encompass a variety of species, and their role in FGR likely depends on which exact species are present.84,85,86
The presence of persistent gut microbial changes into adulthood suggests that the gut microbiome may be a logical target for intervention to improve outcomes following FGR. Multiple probiotic strains have shown protective effects against necrotizing enterocolitis.87 Other groups have shown that targeted additions to a child’s diet can influence health through the microbiome. In term infants, addition of human milk oligosaccharides to infant formula altered the fecal microbiome and decreased incidence of respiratory illnesses and antibiotic use.18 In later childhood, malnourished children fed a nutritional supplement targeting the microbiome had greater weight recovery compared to children fed conventional nutritional therapeutic foods.19 However, whether gut microbial changes are similarly found in human adults who experienced FGR is not yet known.
Although the present study has many strengths, it has several limitations. We selected a calorie-restriction model for its translatability to maternal undernutrition, a common cause of FGR worldwide.1 Alternative models of FGR include isocaloric low protein diet,11,12 late-gestation mesenteric uterine artery ligation,88 or infusion of a thromboxane A2 analog,89,90 although published studies report milder growth restriction compared to our model. Offspring metabolic outcomes are likely to differ based on the specific model used. We studied offspring into early adulthood which may have limited our detection of certain growth and metabolic endpoints. Studying animals until 6–9 months of age may clarify the true extent of FGR’s longstanding effects.12,43 While the tests we performed give broad information about glucose handling, future studies with insulin tolerance testing and/or metabolic clamp studies11,46 may further characterize the effects of FGR on glycemic control and elucidate underlying mechanisms. Our use of 16 S sequencing did not allow for identification of specific species nor functional changes of bacteria. We also did not investigate the basis for persistent changes in the microbiome, such as the intestinal microenvironment or other host-microbe interactions. Finally, the association between FGR and gut microbial changes does not prove causation. More studies are needed to determine what mechanistic role, if any, the microbiome plays in metabolic outcomes.
In conclusion, weaning to a high fat diet led to adverse outcomes in male FGR mice compared to controls. FGR mice of both sexes had fecal microbial differences into adulthood, in particular depletion of Akkermansia in male offspring. The gut microbiome is a modifiable aspect of health which may be contributing to adverse outcomes associated with FGR and should be targeted for future study.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on request.
References
Lee, A. C. et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21(st) standard: analysis of CHERG datasets. BMJ 358, j3677 (2017).
Kesavan, K. & Devaskar, S. U. Intrauterine growth restriction: postnatal monitoring and outcomes. Pediatr. Clin. North Am. 66, 403–423 (2019).
Boehmer, B. H., Limesand, S. W. & Rozance, P. J. The impact of IUGR on pancreatic islet development and beta-cell function. J. Endocrinol. 235, R63–R76 (2017).
Brown, L. D. & Hay, W. W. Jr Impact of placental insufficiency on fetal skeletal muscle growth. Mol. Cell Endocrinol. 435, 69–77 (2016).
Longo, S. et al. Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J. Matern. Fetal Neonatal Med. 26, 222–225 (2013).
Goyal, D., Limesand, S. W. & Goyal, R. Epigenetic responses and the developmental origins of health and disease. J. Endocrinol. 242, T105–T119 (2019).
Pylipow, M. et al. Early postnatal weight gain, intellectual performance, and body mass index at 7 years of age in term infants with intrauterine growth restriction. J. Pediatr. 154, 201–206 (2009).
Ong, K. K., Ahmed, M. L., Emmett, P. M., Preece, M. A. & Dunger, D. B. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 320, 967–971 (2000).
Gishti, O. et al. Fetal and infant growth patterns associated with total and abdominal fat distribution in school-age children. J. Clin. Endocrinol. Metab. 99, 2557–2566 (2014).
Vogelezang, S. et al. Associations of fetal and infant weight change with general, visceral, and organ adiposity at school age. JAMA Netw. Open 2, e192843 (2019).
Berends, L. M. et al. Programming of central and peripheral insulin resistance by low birthweight and postnatal catch-up growth in male mice. Diabetologia 61, 2225–2234 (2018).
Bol, V. V., Delattre, A. I., Reusens, B., Raes, M. & Remacle, C. Forced catch-up growth after fetal protein restriction alters the adipose tissue gene expression program leading to obesity in adult mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R291–R299 (2009).
Ong, K. K. et al. Postnatal growth in preterm infants and later health outcomes: a systematic review. Acta Paediatr. 104, 974–986 (2015).
Hesse, H. et al. Differences in body composition and growth persist postnatally in fetuses diagnosed with severe compared to mild fetal growth restriction. J. Neonatal Perinat. Med 15, 589–598 (2022).
Rozance, P. J. & Hay, W. W. Jr Describing hypoglycemia-definition or operational threshold? Early Hum. Dev. 86, 275–280 (2010).
Iwasa, T. et al. The effects of prenatal undernutrition and a high-fat postnatal diet on central and peripheral orexigenic and anorexigenic factors in female rats. Endocr. J. 64, 597–604 (2017).
Ovilo, C. et al. Prenatal programming in an obese swine model: sex-related effects of maternal energy restriction on morphology, metabolism and hypothalamic gene expression. Br. J. Nutr. 111, 735–746 (2014).
Berger, B. et al. Linking human milk oligosaccharides, infant fecal community types, and later risk to require antibiotics. mBio 11 https://doi.org/10.1128/mBio.03196-19 (2020).
Chen, R. Y. et al. A microbiota-directed food intervention for undernourished children. N. Engl. J. Med. 384, 1517–1528 (2021).
David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014).
Heiss, C. N. & Olofsson, L. E. Gut microbiota-dependent modulation of energy metabolism. J. Innate Immun. 10, 163–171 (2018).
Gensollen, T., Iyer, S. S., Kasper, D. L. & Blumberg, R. S. How colonization by microbiota in early life shapes the immune system. Science 352, 539–544 (2016).
Walker, W. A. The importance of appropriate initial bacterial colonization of the intestine in newborn, child, and adult health. Pediatr. Res. 82, 387–395 (2017).
Sarkar, A., Yoo, J. Y., Valeria Ozorio Dutra, S., Morgan, K. H. & Groer, M. The association between early-life gut microbiota and long-term health and diseases. J. Clin. Med. 10. https://doi.org/10.3390/jcm10030459 (2021).
Zhang, W. et al. Gut microbiota of newborn piglets with intrauterine growth restriction have lower diversity and different taxonomic abundances. J. Appl. Microbiol. 127, 354–369 (2019).
Fanca-Berthon, P., Hoebler, C., Mouzet, E., David, A. & Michel, C. Intrauterine growth restriction not only modifies the cecocolonic microbiota in neonatal rats but also affects its activity in young adult rats. J. Pediatr. Gastroenterol. Nutr. 51, 402–413 (2010).
Yang, J. et al. Unfavourable intrauterine environment contributes to abnormal gut microbiome and metabolome in twins. Gut 71, 2451–2462 (2022).
Zarate, M. A. et al. The acute hepatic NF-kappaB-mediated proinflammatory response to endotoxemia is attenuated in intrauterine growth-restricted newborn mice. Front. Immunol. 12, 706774 (2021).
Chen, P. Y. et al. Intrauterine calorie restriction affects placental DNA methylation and gene expression. Physiol. Genomics 45, 565–576 (2013).
Tanaka, T. The relationships between litter size, offspring weight, and behavioral development in laboratory mice Mus musculus. Mammal. Study 29, 147–153 (2004).
Epstein, H. T. The effect of litter size on weight gain in mice. J. Nutr. 108, 120–123 (1978).
Benede-Ubieto, R., Estevez-Vazquez, O., Ramadori, P., Cubero, F. J. & Nevzorova, Y. A. Guidelines and considerations for metabolic tolerance tests in mice. Diabetes Metab. Syndr. Obes. 13, 439–450 (2020).
Gilley, S. P. et al. Associations between maternal obesity and offspring gut microbiome in the first year of life. Pediatr. Obes. 17, e12921 (2022).
McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8, e61217 (2013).
Liu, C., Cui, Y., Li, X. & Yao, M. microeco: an R package for data mining in microbial community ecology. FEMS Microbiol. Ecol. 97 https://doi.org/10.1093/femsec/fiaa255 (2021).
Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021).
Ruebel, M. L. et al. Associations between maternal diet, body composition and gut microbial ecology in pregnancy. Nutrients 13. https://doi.org/10.3390/nu13093295 (2021).
Louca, S., Parfrey, L. W. & Doebeli, M. Decoupling function and taxonomy in the global ocean microbiome. Science 353, 1272–1277 (2016).
Quinn, T. P. et al. A field guide for the compositional analysis of any-omics data. Gigascience 8. https://doi.org/10.1093/gigascience/giz107 (2019).
Gloor, G. B., Macklaim, J. M., Pawlowsky-Glahn, V. & Egozcue, J. J. Microbiome datasets are compositional: and this is not optional. Front. Microbiol. 8, 2224 (2017).
Savitsky, B. et al. Environmental mismatch and obesity in humans: the Jerusalem perinatal family follow-up study. Int J. Obes. (Lond.) 45, 1404–1417 (2021).
Kim, J., Choi, A. & Kwon, Y. H. Maternal protein restriction altered insulin resistance and inflammation-associated gene expression in adipose tissue of young adult mouse offspring in response to a high-fat diet. Nutrients 12. https://doi.org/10.3390/nu12041103 (2020).
Radford, B. N. & Han, V. K. M. Offspring from maternal nutrient restriction in mice show variations in adult glucose metabolism similar to human fetal growth restriction. J. Dev. Orig. Health Dis. 10, 469–478 (2019).
Wankhade, U. D. et al. Maternal high-fat diet programs offspring liver steatosis in a sexually dimorphic manner in association with changes in gut microbial ecology in mice. Sci. Rep. 8, 16502 (2018).
McCoin, C. S. et al. Sex modulates hepatic mitochondrial adaptations to high-fat diet and physical activity. Am. J. Physiol. Endocrinol. Metab. 317, E298–E311 (2019).
Ayala, J. E. et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Model Mech. 3, 525–534 (2010).
Alur, P. Sex differences in nutrition, growth, and metabolism in preterm infants. Front Pediatr. 7, 22 (2019).
Wang, K. C. W. et al. Foetal growth restriction in mice modifies postnatal airway responsiveness in an age and sex-dependent manner. Clin. Sci. (Lond.) 132, 273–284 (2018).
Sreekantha, S., Wang, Y., Sakurai, R., Liu, J. & Rehan, V. K. Maternal food restriction-induced intrauterine growth restriction in a rat model leads to sex-specific adipogenic programming. FASEB J. 34, 16073–16085 (2020).
Darby, J. R. T., Chiu, J., Regnault, T. R. H. & Morrison, J. L. Placental insufficiency induces a sexually dimorphic response in the expression of cardiac growth and metabolic signalling molecules upon exposure to a postnatal western diet in guinea pigs. J. Dev. Orig. Health Dis. 13, 345–357 (2022).
Muralimanoharan, S. et al. Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction. J. Mol. Cell Cardiol. 108, 181–193 (2017).
Tchoukalova, Y. D. et al. Fetal baboon sex-specific outcomes in adipocyte differentiation at 0.9 gestation in response to moderate maternal nutrient reduction. Int J. Obes. (Lond.) 38, 224–230 (2014).
García-Muñoz Rodrigo, F. et al. Survival and survival without major morbidity seem to be consistently better throughout gestational age in 24- to 30-week gestational age very-low-birth-weight female infants compared to males. Neonatology 119, 585–593 (2022).
Yuan, Z. et al. Feeding intolerance alters the gut microbiota of preterm infants. PLoS One 14, e0210609 (2019).
Liu, L. et al. Early gut microbiota in very low and extremely low birth weight preterm infants with feeding intolerance: a prospective case-control study. J. Microbiol. 60, 1021–1031 (2022).
Tadros, J. S. et al. Postnatal growth and gut microbiota development influenced early childhood growth in preterm infants. Front Pediatr. 10, 850629 (2022).
Younge, N. E. et al. Disrupted maturation of the microbiota and metabolome among extremely preterm infants with postnatal growth failure. Sci. Rep. 9, 8167 (2019).
Shah, P., Nathan, E., Doherty, D. & Patole, S. Prolonged exposure to antibiotics and its associations in extremely preterm neonates-the Western Australian experience. J. Matern Fetal Neonatal Med. 26, 1710–1714 (2013).
Shah, P., Nathan, E., Doherty, D. & Patole, S. Optimising enteral nutrition in growth restricted extremely preterm neonates-a difficult proposition. J. Matern Fetal Neonatal Med. 28, 1981–1984 (2015).
Malhotra, A. et al. Neonatal morbidities of fetal growth restriction: pathophysiology and impact. Front. Endocrinol. (Lausanne) 10, 55 (2019).
Tang, W. et al. Metabolome, microbiome, and gene expression alterations in the colon of newborn piglets with intrauterine growth restriction. Front Microbiol. 13, 989060 (2022).
Zhang, J. et al. Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes. Adv. Sci. (Weinh.) 8, e2100536 (2021).
Hasani, A. et al. The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis. J. Med. Microbiol. 70 (2021). https://doi.org/10.1099/jmm.0.001435 (2021).
Shin, J. et al. Elucidation of Akkermansia muciniphila probiotic traits driven by mucin depletion. Front Microbiol. 10, 1137 (2019).
Dao, M. C. et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426–436 (2016).
Dao, M. C. et al. Akkermansia muciniphila abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement. Am. J. Physiol. Endocrinol. Metab. 317, E446–e459 (2019).
Ghotaslou, R. et al. The metabolic, protective, and immune functions of Akkermansia muciniphila. Microbiol. Res. 266, 127245 (2023).
Pan, X. et al. Gut microbiota, glucose, lipid, and water-electrolyte metabolism in children with nonalcoholic fatty liver disease. Front Cell Infect. Microbiol. 11, 683743 (2021).
Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25, 1096–1103 (2019).
Fung, C. M. et al. Intrauterine growth restriction alters mouse intestinal architecture during development. PLoS One 11, e0146542 (2016).
Dong, L. et al. Supplementation of tributyrin improves the growth and intestinal digestive and barrier functions in intrauterine growth-restricted piglets. Clin. Nutr. 35, 399–407 (2016).
Santos, T. G. et al. Intrauterine growth restriction and its impact on intestinal morphophysiology throughout postnatal development in pigs. Sci. Rep. 12, 11810 (2022).
Liu, Y. et al. Intrauterine growth retardation affects liver bile acid metabolism in growing pigs: effects associated with the changes of colonic bile acid derivatives. J. Anim. Sci. Biotechnol. 13, 117 (2022).
Srikanthan, P. & Karlamangla, A. S. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J. Clin. Endocrinol. Metab. 96, 2898–2903 (2011).
Byeon, H. R. et al. New strains of Akkermansia muciniphila and Faecalibacterium prausnitzii are effective for improving the muscle strength of mice with immobilization-induced muscular atrophy. J. Med. Food 25, 565–575 (2022).
Benitez-Paez, A. et al. Depletion of Blautia species in the microbiota of obese children relates to intestinal inflammation and metabolic phenotype worsening. mSystems 5. https://doi.org/10.1128/mSystems.00857-19 (2020).
Ozato, N. et al. Blautia genus associated with visceral fat accumulation in adults 20–76 years of age. NPJ Biofilms Microbiomes 5, 28 (2019).
Liu, X. et al. Blautia-a new functional genus with potential probiotic properties? Gut Microbes 13, 1–21 (2021).
Alrehaili, B. D. et al. Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mice. Hepatol. Commun. 6, 2765–2780 (2022).
Kivenson, V. & Giovannoni, S. J. An expanded genetic code enables trimethylamine metabolism in human gut bacteria. mSystems 5. https://doi.org/10.1128/mSystems.00413-20 (2020).
Natividad, J. M. et al. Bilophila Wadsworth aggravates high fat diet induced metabolic dysfunctions in mice. Nat. Commun. 9, 2802 (2018).
Feng, Z. et al. A human stool-derived Bilophila Wadsworth strain caused systemic inflammation in specific-pathogen-free mice. Gut Pathog. 9, 59 (2017).
Maldonado-Arriaga, B. et al. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis. Microbiologyopen 10, e1181 (2021).
Stuivenberg, G. A., Burton, J. P., Bron, P. A. & Reid, G. Why are bifidobacteria important for infants? Microorganisms 10. https://doi.org/10.3390/microorganisms10020278 (2022).
Hiippala, K., Kainulainen, V., Kalliomäki, M., Arkkila, P. & Satokari, R. Mucosal prevalence and interactions with the epithelium indicate commensalism of Sutterella spp. Front. Microbiol. 7, 1706 (2016).
Devika, N. T. & Raman, K. Deciphering the metabolic capabilities of Bifidobacteria using genome-scale metabolic models. Sci. Rep. 9, 18222 (2019).
Beghetti, I. et al. Probiotics for preventing necrotizing enterocolitis in preterm infants: a network meta-analysis. Nutrients 13. https://doi.org/10.3390/nu13010192 (2021).
Habli, M., Jones, H., Aronow, B., Omar, K. & Crombleholme, T. M. Recapitulation of characteristics of human placental vascular insufficiency in a novel mouse model. Placenta 34, 1150–1158 (2013).
Fung, C. et al. Novel thromboxane A2 analog-induced IUGR mouse model. J. Dev. Orig. Health Dis. 2, 291–301 (2011).
Gibbins, K. J. et al. Effects of excess thromboxane A2 on placental development and nutrient transporters in a Mus musculus model of fetal growth restriction. Biol. Reprod. 98, 695–704 (2018).
Acknowledgements
M.A.Z. is now at Eli Lilly and Company. Thank you to Ginger Johnson, Matthew Jackman, and Claudia Solt for technical assistance with body composition and calorimetry studies.
Funding
These studies were supported in part by a grant from the Ludeman Family Center for Women’s Health Research (S.P.G.), and NIH grants R01HL132941 (C.J.W.), R01HD107700 (C.J.W.); and 1R01HD093701 (P.J.R.). K.S. is supported in part by grants from the NIH (5 P30DK048520 and 1 R01HD102726) and funds from the Department of Pediatrics, University of Colorado Anschutz Medical Campus and the Anschutz Health and Wellness Center. S.P.G. was supported by NIH T32DK007658. P.S.M. is supported by the Colorado Special Center on Research Excellence (NIH U54 AG062319). The studies utilized cores and facilities in the Colorado Nutrition Obesity Research Center (NIH P30 DK48520).
Author information
Authors and Affiliations
Contributions
S.P.G., M.A.Z., L.Z., P.S.M., C.J.W., P.J.R., and K.S. conceived and designed the study. S.P.G., M.A.Z., L.Z., P.J., and D.Y. carried out experimentation and data collection. S.P.G., P.J., M.A.Z., D.Y., S.V.M., P.S.M., C.J.W., P.J.R., and K.S. analyzed data. S.P.G. developed the draft of the paper. All authors were involved in writing the paper and had final approval of the submitted and published versions.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gilley, S.P., Zarate, M.A., Zheng, L. et al. Metabolic and fecal microbial changes in adult fetal growth restricted mice. Pediatr Res 95, 647–659 (2024). https://doi.org/10.1038/s41390-023-02869-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-023-02869-8
- Springer Nature America, Inc.